[1]
Batta, A., Hazarika, K., Varshney, D. and Gugnani, R. 2026. Comparison of the efficacy and safety of hydroxychloroquine versus teneligliptin as add on therapy in uncontrolled type 2 diabetes mellitus: a randomized, prospective and open labelled study. International Journal of Basic & Clinical Pharmacology. 15, 2 (Feb. 2026), 276–282. DOI:https://doi.org/10.18203/2319-2003.ijbcp20260427.